Skip to content


Naglazyme (galsulfase) is an enzyme pharmaceutical. Galsulfase was first approved as Naglazyme on 2005-05-31. It is used to treat mucopolysaccharidosis VI in the USA. It has been approved in Europe to treat mucopolysaccharidosis VI.
Trade Name Naglazyme
Common Name Galsulfase
Indication mucopolysaccharidosis vi
Drug Class Enzymes
Get full access now